...
首页> 外文期刊>Acta pharmaceutica: a quarterly journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, dealing with all branches of pharmacy and allied sciences >Synthesis of thiophene and N-substituted thieno[3,2-d]pyrimidine derivatives as potent antitumor and antibacterial agents
【24h】

Synthesis of thiophene and N-substituted thieno[3,2-d]pyrimidine derivatives as potent antitumor and antibacterial agents

机译:噻吩和N-取代的Thieno [3,2-D]嘧啶衍生物作为有效抗肿瘤和抗菌剂的合成

获取原文
获取原文并翻译 | 示例
           

摘要

A novel series of carbamothioylamino-benzene-sulfonamide-thiophene-carboxylates 4a-c and thieno[3,2-d]pyrimidin-2yl-amino-benzene-sulfonamides 5a-c were synthesized in a series of synthetic steps and were used as key intermediates for the synthesis of thienotriazolopyrimidine-benzene-sulfonamide derivatives 6a-c and 7a-c. Thieno[3,2-d]pyrimidin-ones (8 and 9) were also prepared. Compound 9 was used as an intermediate for the synthesis of imidazole/1,2,4-triazole and tetrazine functionalized thieno[3,2-d]pyrimidine derivatives (10-12). Pyrrole derivatives/pyrrolopyrimidine/pyrrolotriazolopyrimidine functionalized thiophenes (15-19) were also synthesized. Structures of the newly synthesized compounds were established by elemental analysis and spectral data. Most of the newly synthesized compounds were evaluated for their in vitro activity against three human tumor cell lines, namely, liver cancer (HepG-2), colon cancer (HT-29) and lung cancer (NCI-H460), using doxorubicin as standard. Compounds 16 (GI(50)= 0.02, 0.04 and 0.06 mu mol L-1, resp.) and 19b (GI(50)= 0.02, 0.03 and 0.05 mu mol L-1 , resp.) showed higher activity against all cell lines than doxorubicin. Most of the compounds were also screened for antibacterial activity using ciprofloxacin as standard drug. Compounds 4b and 6b, both containing benzenesulfonamide linked to N-,10 bearing imidazole moiety, and 15 and 19b,c with a thiophene-2-carboxylic acid chain, exhibited high activity against Gram-positive and Gram-negative bacteria.
机译:在一系列合成步骤中合成了一种新颖的氨基硫氰胺 - 苯磺胺酰胺 - 噻吩 - 羧酸酯4A-C和Thieno [3,2-D]嘧啶-200L-氨基 - 苯磺胺酰氨基 - 苯胺 - 磺胺酰氨基 - 磺胺酰氨基 - 苯胺。用作键用于合成硫代唑嘧啶 - 苯磺酰胺衍生物6a-c和7a-c的中间体。还制备了噻吩[3,2-D]嘧啶 - 嘧啶(8和9)。化合物9用作合成咪唑/ 1,2,4-三唑和四嗪官能化噻吩的中间体[3,2-D]嘧啶衍生物(10-12)。吡咯衍生物/吡咯基嘧啶/吡咯三唑胺官能化噻吩(15-19)也被合成。通过元素分析和光谱数据建立新合成化合物的结构。使用多柔比蛋白作为标准,评估大多数新合成的化合物对三种人肿瘤细胞系,即肝癌(HepG-2),结肠癌(HT-29)和肺癌(NCI-H460)的体外活性进行评估。化合物16(GI(50)= 0.02,0.04和0.06 mol L-1,REAC。)和19b(GI(50)= 0.02,0.03和0.05μmL1-1,REAC。)对所有细胞显示出更高的活性系列比多柔比星。还使用环丙沙星作为标准药物筛选大多数化合物用于抗菌活性。含有与N-,10亚咪唑部分连接的苯磺胺酰胺和15和19B,C的化合物4B和6B含有噻吩-2-羧酸链,对革兰氏阳性和革兰氏阴性细菌的高活性表现出高活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号